Benzinga - The Dow Jones closed slightly higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Cocrystal Pharma
- The Trade: Cocrystal Pharma, Inc. (NASDAQ: COCP) Frost Gamma Investments Trust acquired a total 1,015,229 shares an average price of $1.97. To acquire these shares, it cost around $2 million.
- What’s Happening: Cocrystal Pharma posted a FY loss of $4.77 per share.
- What Cocrystal Pharma Does: Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses.
- The Trade: OncoCyte Corporation (NASDAQ: OCX) 10% owner Efrem Kamen acquired a total of 663,000 shares at an average price of $0.30. The insider spent around $200.03 thousand to buy those shares.
- What’s Happening: Oncocyte announced a $13.86 million public offering.
- What OncoCyte Does: OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Xos
- The Trade: Xos, Inc. (NASDAQ: XOS) Director George N Mattson acquired a total of 106,039 shares at an average price of $0.60. To acquire these shares, it cost around $64.08 thousand.
- What’s Happening: Xos posted a narrower-than-expected quarterly loss.
- What Xos Does: Xos Inc is an electric mobility company. It designs and develops fully electric battery mobility systems specifically for commercial fleets.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.